Illumina Begin Period Cash Flow from 2010 to 2025

ILMN Stock  USD 85.68  0.08  0.09%   
Illumina Begin Period Cash Flow yearly trend continues to be very stable with very little volatility. Begin Period Cash Flow is likely to drop to about 647.5 M. Begin Period Cash Flow is the amount of cash Illumina has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. View All Fundamentals
 
Begin Period Cash Flow  
First Reported
2000-03-31
Previous Quarter
920 M
Current Value
869 M
Quarterly Volatility
804.6 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Illumina financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Illumina's main balance sheet or income statement drivers, such as Depreciation And Amortization of 371.7 M, Interest Expense of 62.2 M or Total Revenue of 4.6 B, as well as many indicators such as Price To Sales Ratio of 5.19, Dividend Yield of 0.0 or PTB Ratio of 5.39. Illumina financial statements analysis is a perfect complement when working with Illumina Valuation or Volatility modules.
  
Check out the analysis of Illumina Correlation against competitors.
To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.

Latest Illumina's Begin Period Cash Flow Growth Pattern

Below is the plot of the Begin Period Cash Flow of Illumina over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. Illumina's Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Illumina's overall financial position and show how it may be relating to other accounts over time.
Begin Period Cash Flow10 Years Trend
Slightly volatile
   Begin Period Cash Flow   
       Timeline  

Illumina Begin Period Cash Flow Regression Statistics

Arithmetic Mean937,824,208
Geometric Mean628,999,165
Coefficient Of Variation65.42
Mean Deviation493,403,818
Median768,770,000
Standard Deviation613,569,556
Sample Variance376467.6T
Range2B
R-Value0.71
Mean Square Error199637.4T
R-Squared0.51
Significance0
Slope91,588,759
Total Sum of Squares5647014T

Illumina Begin Period Cash Flow History

2025647.5 M
2024B
2023B
20221.2 B
20211.8 B
2020B
20191.1 B

About Illumina Financial Statements

Illumina investors utilize fundamental indicators, such as Begin Period Cash Flow, to predict how Illumina Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Begin Period Cash FlowB647.5 M

Pair Trading with Illumina

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Illumina position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Illumina will appreciate offsetting losses from the drop in the long position's value.

Moving together with Illumina Stock

  0.67A Agilent TechnologiesPairCorr
  0.93ME 23Andme HoldingPairCorr

Moving against Illumina Stock

  0.9VALN Valneva SE ADR Earnings Call TodayPairCorr
  0.79DVAX Dynavax TechnologiesPairCorr
  0.6VIGL Vigil NeurosciencePairCorr
  0.57DMAC DiaMedica TherapeuticsPairCorr
  0.56EQ EquilliumPairCorr
The ability to find closely correlated positions to Illumina could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Illumina when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Illumina - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Illumina to buy it.
The correlation of Illumina is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Illumina moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Illumina moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Illumina can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Illumina offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Illumina's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Illumina Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Illumina Stock:
Check out the analysis of Illumina Correlation against competitors.
To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.96)
Earnings Share
(7.69)
Revenue Per Share
27.497
Quarterly Revenue Growth
(0.02)
Return On Assets
0.0264
The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.